We are live on
!
Find out more
RCA
Riverview Capital Advisers Portfolio holdings
AUM
$300M
1-Year Est. Return
10.98%
This Fund
S&P 500
This Quarter
Est. Return
+9.65%
1 Year Est. Return
+10.98%
3 Year Est. Return
+57.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$225M
AUM Growth
–
Cap. Flow
+$220M
Cap. Flow
% of AUM
97.73%
Top 10 Holdings %
Top 10 Hldgs %
45.88%
Holding
104
New
104
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$17.5M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$12.3M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$11.8M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$11.5M |
| 5 |
iShares Russell 2000 Value ETF
IWN
|
+$10.3M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.16% |
| 2 | Financials | 14.58% |
| 3 | Consumer Discretionary | 9.97% |
| 4 | Communication Services | 8.21% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Micron Technology
MU
$930B
| $2.61M | 1.16% |
+27,985
| New | +$2.19M |
|
27
Moderna
MRNA
$21.8B
| $2.55M | 1.14% |
+10,050
| New | +$2.94M |
|
28
Labcorp
LH
$25B
| $2.51M | 1.12% |
+9,312
| New | +$2.31M |
|
29
CVS Health
CVS
$133B
| $2.45M | 1.09% |
+23,734
| New | +$2.19M |
|
30
Phillips 66
PSX
$84.9B
| $2.39M | 1.06% |
+32,954
| New | +$2.49M |
|
31
Visa
V
$684B
| $2.29M | 1.02% |
+10,583
| New | +$2.27M |
|
32
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $2.28M | 1.01% |
+9,436
| New | +$2.23M |
|
33
Tesla
TSLA
$1.23T
| $2.11M | 0.94% |
+5,994
| New | +$2.01M |
|
34
Simon Property Group
SPG
$74.4B
| $2.07M | 0.92% |
+12,970
| New | +$1.98M |
|
35
Waste Management
WM
$90.6B
| $2.05M | 0.91% |
+12,282
| New | +$1.97M |
|
36
Performance Food Group
PFGC
$18B
| $1.57M | 0.7% |
+34,165
| New | +$1.55M |
|
37
Vanguard Industrials ETF
VIS
$8.1B
| $1.52M | 0.67% |
+7,467
| New | +$1.49M |
|
38
Medtronic
MDT
$109B
| $1.51M | 0.67% |
+14,627
| New | +$1.69M |
|
39
Pfizer
PFE
$143B
| $1.45M | 0.64% |
+24,532
| New | +$1.22M |
|
40
Quest Diagnostics
DGX
$25.7B
| $1.41M | 0.63% |
+8,168
| New | +$1.24M |
|
41
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $1.26M | 0.56% |
+2,643
| New | +$1.21M |
|
42
Carrier Global
CARR
$51B
| $1.24M | 0.55% |
+22,887
| New | +$1.24M |
|
43
Johnson & Johnson
JNJ
$618B
| $1.2M | 0.54% |
+7,027
| New | +$1.15M |
|
44
Lockheed Martin
LMT
$134B
| $1.19M | 0.53% |
+3,345
| New | +$1.16M |
|
45
Salesforce
CRM
$151B
| $1.18M | 0.53% |
+4,645
| New | +$1.31M |
|
46
Aflac
AFL
$64.9B
| $1.16M | 0.52% |
+19,835
| New | +$1.11M |
|
47
Stryker
SYK
$125B
| $1.16M | 0.51% |
+4,320
| New | +$1.13M |
|
48
VF Corp
VFC
$5.63B
| $1.15M | 0.51% |
+15,715
| New | +$1.15M |
|
49
iShares US Technology ETF
IYW
$23.6B
| $1.13M | 0.5% |
+9,834
| New | +$1.09M |
|
50
RTX Corp
RTX
$290B
| $1.13M | 0.5% |
+13,092
| New | +$1.14M |
|
Similar funds
UCB
KEM
RP
I
SC
GB
FPCG
CG
Riverview Capital Advisers's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Riverview Capital Advisers, which disclosed 104 positions worth $225M. Its ten largest holdings account for 46% of the portfolio.
Its largest position is Apple: 110,791 shares worth $19.7M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, followed by Financials and Consumer Discretionary.
- Riverview Capital Advisers's largest Q4 2021 buy was Apple: 110,791 shares worth $19.7M.
- Riverview Capital Advisers's ten largest holdings make up 46% of its $225M portfolio in Q4 2021.
- Riverview Capital Advisers disclosed 104 positions in Q4 2021, its first 13F filing on record.
Based on Riverview Capital Advisers's 13F filing for Q4 2021, filed 7 Feb 2023.